"Designing Growth Strategies is in our DNA"

Psoriatic Arthritis Treatment Market Size, Share & COVID-19 Impact Analysis, By Drugs Class (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Forecast, 2020-2027

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101066

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Psoriatic Arthritis for Key Countries/Region
    2. Recent Industry Developments Such as Partnerships, Mergers & Acquisitions, New Product Launches Etc.
    3. Pipeline Analysis for Key Companies
    4. Regulatory Framework by Key Countries
    5. Impact of COVID-19 on Psoriatic Arthritis Treatment Market
  5. Global Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
      3. Biologic Disease Modifying Anti-Rheumatic Drugs
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
      3. Biologic Disease Modifying Anti-Rheumatic Drugs
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Non-steroidal Anti-inflammatory Drugs
      2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
      3. Biologic Disease Modifying Anti-Rheumatic Drugs
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    5. Market Analysis – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
      3. Biologic Disease Modifying Anti-Rheumatic Drugs
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    5. Market Analysis – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      2. Non-biologic Disease Modifying Anti-Rheumatic Drugs
      3. Biologic Disease Modifying Anti-Rheumatic Drugs
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    5. Market Analysis – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
      2. Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
      3. Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online pharmacies
    5. Market Analysis – By Country/Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Company Profiles (Overview, Products, SWOT, Recent developments, strategies, financials (based on availability))
      1. AbbVie Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Novartis AG
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Johnson & Johnson Services, Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Pfizer Inc.,
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. LEO Pharma A/S
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Merck & Co., Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Amgen Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Eli Lilly and Company
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. CELGENE CORPORATION
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. UCB S.A.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      11. Sun Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      12. Other prominent players
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Psoriatic Arthritis Treatment Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027

Figure 2:  Global Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2019 & 2027

Figure 3:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Non-Steroidal Anti-inflammatory Drugs (NSAIDS), 2016-2027

Figure 4:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Non-Biologic Disease Modifying Anti-Rheumatic Drugs, 2016-2027

Figure 5:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Biologic Disease Modifying Anti-Rheumatic Drugs, 2016-2027

Figure 6:  Global Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2019 & 2027

Figure 7:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Oral, 2016-2027

Figure 8:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Parenteral, 2016-2027

Figure 9:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Topical, 2016-2027

Figure 10:  Global Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 11:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Hospital Pharmacies, 2016-2027

Figure 12:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Retail Pharmacies, 2016-2027

Figure 13:  Global Psoriatic Arthritis Treatment Market Forecast (USD Billion), by Online Pharmacies, 2016-2027

Figure 14:  Global Psoriatic Arthritis Treatment Market Value (USD Billion), by Region, 2019 & 2027

Figure 15:  North America Psoriatic Arthritis Treatment Market Value (USD Billion), by Drug Class, 2019 & 2027

Figure 16:  North America Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2019

Figure 17:  North America Psoriatic Arthritis Treatment Market Value (USD Billion), by Route of Administration, 2019 & 2027

Figure 18:  North America Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2019

Figure 19:  North America Psoriatic Arthritis Treatment Market Value (USD Billion), by Distribution Channel, 2019 & 2027

Figure 20:  North America Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 21:  North America Psoriatic Arthritis Treatment Market Value (USD Billion), By Country, 2019 & 2027

Figure 22:  North America Psoriatic Arthritis Treatment Market Value Share (%), By Country, 2019

Figure 23:  Europe Psoriatic Arthritis Treatment Market Value (USD Billion), by Drug Class, 2019 & 2027

Figure 24:  Europe Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2019

Figure 25:  Europe Psoriatic Arthritis Treatment Market Value (USD Billion), by Route of Administration, 2019 & 2027

Figure 26:  Europe Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2019

Figure 27:  Europe Psoriatic Arthritis Treatment Market Value (USD Billion), by Distribution Channel, 2019 & 2027

Figure 28:  Europe Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 29:  Europe Psoriatic Arthritis Treatment Market Value (USD Billion), By Country/ Sub-region, 2019 & 2027

Figure 30:  Europe Psoriatic Arthritis Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 31:  Asia Pacific Psoriatic Arthritis Treatment Market Value (USD Billion), by Drug Class, 2019 & 2027

Figure 32:  Asia Pacific Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2019

Figure 33:  Asia Pacific Psoriatic Arthritis Treatment Market Value (USD Billion), by Route of Administration, 2019 & 2027

Figure 34:  Asia Pacific Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2019

Figure 35:  Asia Pacific Psoriatic Arthritis Treatment Market Value (USD Billion), by Distribution Channel, 2019 & 2027

Figure 36:  Asia Pacific Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 37:  Asia Pacific Psoriatic Arthritis Treatment Market Value (USD Billion), By Country/ Sub-region, 2019 & 2027

Figure 38:  Asia Pacific Psoriatic Arthritis Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 39:  Latin America Psoriatic Arthritis Treatment Market Value (USD Billion), by Drug Class, 2019 & 2027

Figure 40:  Latin America Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2019

Figure 41:  Latin America Psoriatic Arthritis Treatment Market Value (USD Billion), by Route of Administration, 2019 & 2027

Figure 42:  Latin America Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2019

Figure 43:  Latin America Psoriatic Arthritis Treatment Market Value (USD Billion), by Distribution Channel, 2019 & 2027

Figure 44:  Latin America Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 45:  Latin America Psoriatic Arthritis Treatment Market Value (USD Billion), By Country/ Sub-region, 2019 & 2027

Figure 46:  Latin America Psoriatic Arthritis Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 47:  Middle East & Africa Psoriatic Arthritis Treatment Market Value (USD Billion), by Drug Class, 2019 & 2027

Figure 48:  Middle East & Africa Psoriatic Arthritis Treatment Market Value Share (%), by Drug Class, 2019

Figure 49:  Middle East & Africa Psoriatic Arthritis Treatment Market Value (USD Billion), by Route of Administration, 2019 & 2027

Figure 50:  Middle East & Africa Psoriatic Arthritis Treatment Market Value Share (%), by Route of Administration, 2019

Figure 51:  Middle East & Africa Psoriatic Arthritis Treatment Market Value (USD Billion), by Distribution Channel, 2019 & 2027

Figure 52:  Middle East & Africa Psoriatic Arthritis Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 53:  Middle East & Africa Psoriatic Arthritis Treatment Market Value (USD Billion), By Country/ Sub-region, 2019 & 2027

Figure 54:  Middle East & Africa Psoriatic Arthritis Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 55:  Global Psoriatic Arthritis Treatment Market Share (%), By Company, 2019

Table 1:  Global Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016–2027

Table 2:  Global Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2016–2027

Table 3:  Global Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016–2027

Table 4:  Global Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Region, 2016-2027

Table 5:  North America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016-2027

Table 6:  North America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2016-2027

Table 7:  North America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 8:  North America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, By Country, 2016-2027

Table 9:  Europe Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016-2027

Table 10:  Europe Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2016-2027

Table 11:  Europe Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 12:  Europe Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2016-2027

Table 13:  Asia Pacific Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016-2027

Table 14:  Asia Pacific Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2016-2027

Table 15:  Asia Pacific Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 16:  Asia Pacific Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2016-2027

Table 17:  Latin America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016-2027

Table 18:  Latin America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2016-2027

Table 19:  Latin America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 20:  Latin America Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2016-2027

Table 21:  Middle East & Africa Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Drug Class, 2016-2027

Table 22:  Middle East & Africa Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Route of Administration, 2016-2027

Table 23:  Middle East & Africa Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 24:  Middle East & Africa Psoriatic Arthritis Treatment Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2016-2027

Psoriatic Arthritis Treatment Market Size, Share and Global Industry Trend Forecast till 2027
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase